Bleomycin sclerotherapy for severe symptomatic and persistent pelvic lymphocele.

Case Rep Obstet Gynecol

Department of Obstetrics and Gynaecology, São João Hospital Center, Portugal.

Published: August 2014

Background. Pelvic lymphoceles are frequently described as a complication of pelvic lymphadenectomy performed for surgical staging of gynaecologic malignancies. Case Report. A 72-year-old woman presented with severe symptomatic and refractory lymphocele associated with persistent lower limb lymphedema and recurrent erysipelas. After four CT fluoroscopy scan guided percutaneous catheter drainages, the lymphocele complicated with infection finally resolved with two sessions of bleomycin sclerotherapy. Conclusion. Symptomatic persistent lymphoceles require treatment and nowadays the first option is interventional radiologic procedures. Bleomycin is a safe and effective sclerosing agent and therefore should be regarded as a first-line treatment choice.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109129PMC
http://dx.doi.org/10.1155/2014/624803DOI Listing

Publication Analysis

Top Keywords

bleomycin sclerotherapy
8
severe symptomatic
8
symptomatic persistent
8
sclerotherapy severe
4
persistent pelvic
4
pelvic lymphocele
4
lymphocele background
4
background pelvic
4
pelvic lymphoceles
4
lymphoceles frequently
4

Similar Publications

Intralesional bleomycin sclerotherapy for head and neck low-flow vascular malformations - A retrospective single-center experience.

J Craniomaxillofac Surg

January 2025

Neuroradiology Department, ULS São José, Lisbon, Portugal; NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal; Centro Clínico Académico de Lisboa (CCAL), Lisbon, Portugal.

Low-flow vascular malformations (LFVMs) account for over 90% of all vascular malformations, with the highest prevalence in the head and neck region. Intralesional sclerotherapy is the treatment of choice for subcutaneous LFVMs, although there is no consensus on optimal agent selection or dosage. Mild sclerosing agents, such as bleomycin, are commonly used in sensitive anatomical areas, including the head and neck, due to their favorable safety profile, despite slightly lower efficacy.

View Article and Find Full Text PDF

Bleomycin sclerotherapy for venous vascular malformations of the tongue.

J Neurointerv Surg

January 2025

Division of Neuroradiology, Toronto Western Hospital, Joint Department of Medical Imaging, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Background: Venous vascular malformations (VVMs) are congenital vascular anomalies, often impacting quality of life due to discomfort, swelling, and functional impairments. This study evaluates the efficacy of bleomycin sclerotherapy as a treatment for symptomatic VVMs of the tongue.

Methods: We conducted a retrospective review of all patients treated with this method in our institution between 2004 and 2024.

View Article and Find Full Text PDF

Lymphangiomas are localized multi-cystic malformations of the lymphatic and vascular system, primarily affecting the head and neck regions in children. Orbital lymphangiomas are not considered hamartomas because the orbit does not commonly display lymphatic vessels. In this case report, we describe a male patient who was 15 years old and presented to our medical facility with the primary complaints of having a bulging left eye, sudden chemosis of the lower conjunctiva, and pain in the left eye.

View Article and Find Full Text PDF

Vascular malformations (VMs) are congenital abnormalities of blood or lymphatic vessels, present at birth and growing proportionally with the individual. They are classified into types such as capillary, venous, lymphatic, and arteriovenous malformation (AVMs). Symptoms include discoloration, swelling, pain, or functional impairment, depending on the type and location.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!